awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52633900-19EDBBCD-F8C5-4E3B-85BD-6C5FCF4022EB
Q52633900-19EDBBCD-F8C5-4E3B-85BD-6C5FCF4022EB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52633900-19EDBBCD-F8C5-4E3B-85BD-6C5FCF4022EB
Transitioning patients with immune thrombocytopenia to second-line therapy: Challenges and best practices.
P2860
Q52633900-19EDBBCD-F8C5-4E3B-85BD-6C5FCF4022EB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52633900-19EDBBCD-F8C5-4E3B-85BD-6C5FCF4022EB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
15df3a423191daf21744f2becfcc9da94a9fa4ea
P2860
Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years duration.